These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29524599)
21. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model. Behere A; Thörnqvist PO; Winberg S; Ingelsson M; Bergström J; Ekmark-Lewén S J Neurosci Res; 2021 Oct; 99(10):2525-2539. PubMed ID: 34292621 [TBL] [Abstract][Full Text] [Related]
22. Minocycline protects, rescues and prevents knockdown transgenic parkin Drosophila against paraquat/iron toxicity: Implications for autosomic recessive juvenile parkinsonism. Ortega-Arellano HF; Jimenez-Del-Rio M; Velez-Pardo C Neurotoxicology; 2017 May; 60():42-53. PubMed ID: 28284907 [TBL] [Abstract][Full Text] [Related]
30. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice. Marxreiter F; Ettle B; May VE; Esmer H; Patrick C; Kragh CL; Klucken J; Winner B; Riess O; Winkler J; Masliah E; Nuber S Neurobiol Dis; 2013 Nov; 59():38-51. PubMed ID: 23867236 [TBL] [Abstract][Full Text] [Related]
31. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287 [TBL] [Abstract][Full Text] [Related]
32. Effect of Genistein on the Transgenic Siddique YH; Naz F; Jyoti S; Ali F; Rahul J Diet Suppl; 2019; 16(5):550-563. PubMed ID: 29969325 [TBL] [Abstract][Full Text] [Related]
33. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity. Olsen AL; Feany MB Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834 [TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of PACAP against paraquat-induced oxidative stress in the Drosophila central nervous system. Hajji K; Mteyrek A; Sun J; Cassar M; Mezghani S; Leprince J; Vaudry D; Masmoudi-Kouki O; Birman S Hum Mol Genet; 2019 Jun; 28(11):1905-1918. PubMed ID: 30715303 [TBL] [Abstract][Full Text] [Related]
35. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688 [TBL] [Abstract][Full Text] [Related]
36. The A30P α-synuclein mutation decreases subventricular zone proliferation. Zhang XM; Anwar S; Kim Y; Brown J; Comte I; Cai H; Cai NN; Wade-Martins R; Szele FG Hum Mol Genet; 2019 Jul; 28(14):2283-2294. PubMed ID: 31267130 [TBL] [Abstract][Full Text] [Related]
37. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease. Kilpeläinen T; Julku UH; Svarcbahs R; Myöhänen TT Sci Rep; 2019 Nov; 9(1):17382. PubMed ID: 31758049 [TBL] [Abstract][Full Text] [Related]
38. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures. Park SS; Lee D Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979 [TBL] [Abstract][Full Text] [Related]
39. Walking deficits and centrophobism in an α-synuclein fly model of Parkinson's disease. Chen AY; Wilburn P; Hao X; Tully T Genes Brain Behav; 2014 Nov; 13(8):812-20. PubMed ID: 25113870 [TBL] [Abstract][Full Text] [Related]
40. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]